Domov › Alzheimerova choroba › Ohio
Klinické štúdie Alzheimerova choroba v štáte Ohio
17 štúdií pre Alzheimerova choroba hľadá účastníkov v zariadeniach v štáte Ohio.
Mestá v štáte Ohio
Oficiálny text štúdie (anglicky)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Dayton
- Clinical Site, Independence
Prebieha náborFáza 2
Vek 55 až 90 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2617, Blue Ash
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Local Institution - 1265, Cleveland
- Ohio State University, Columbus
- Local Institution - 1258, Dayton
- a 1 ďalších
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- NDx Clinical Research, Dayton
Prebieha náborFáza 2
Vek 55 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Ohio State University, Columbus
Prebieha náborFáza 3
Vek 50 až 90 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Velocity Clinical Research - Blue Ash, Blue Ash
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Cleveland Clinic, Cleveland
- Local Institution - 0087, Columbus
Prebieha náborFáza 2
Vek 55 až 90 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Insight Clinical Trials ( Site 1011), Independence
- Neuro-Behavioral Clinical Research ( Site 1028), North Canton
Prebieha náborFáza 2
Vek 50 až 85 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Ohio State University, Columbus
- NDx Clinical Research Inc., Dayton
Prebieha náborFáza 3
Vek 60 až 85 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Cleveland Clinic, Cleveland
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06563895A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- NDx Clinical Research, Inc., Dayton
- Care Access - Lima, Lima
Prebieha náborFáza 3
Vek 55 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Local Institution - 0029, Cleveland
- Insight Clinical Trials LLC - Independence, Independence
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 30. 6. 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- The Ohio State University, Columbus
Prebieha náborFáza 2
Vek 50 až 85 · Všetky pohlavia · Aktualizované 26. 6. 2026 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Insight Clinical Trials LLC, Beachwood
- Valley Medical Research, Centerville
Prebieha náborFáza 3
Vek 50 a viac · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Case Western Reserve University, Beachwood
- University of Cincinnati, Cincinnati
Prebieha náborObservačná štúdia
Vek 25 až 55 · Všetky pohlavia · Aktualizované 18. 5. 2026 · NCT04165109Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- Ohio University, Athens
- The Ohio State University, Columbus
Prebieha nábor
Vek 60 a viac · Všetky pohlavia · Aktualizované 5. 3. 2026 · NCT05748613Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- The Ohio State University, Columbus
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 3. 2025 · NCT03019757Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.